Board of Governors Roster

	R. John Collier, Chair of the Board of Governors Maude and Lillian Presley Professor of Microbiology and Molecular Genetics Harvard University Medical School Boston, Massachusetts Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Collier’s research is aimed at understanding the structures and modes of action of protein toxins that are responsible for major symptoms of many bacterial diseases. He is currently focusing on anthrax toxin, applying genetic, biochemical, and biophysical methods to generate detailed models of each step in toxin action. This line of investigation has revealed new approaches to treating and vaccinating against anthrax.
	Edward F. DeLong Professor, Department of Biological Engineering & Department of Civil and Environmental Engineering Massachusetts Institute of Technology Cambridge, Massachusetts Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. DeLong works to develop the field of microbial community genomics and metagenomics, which involves defining and mapping the intersections of gene, organism and environmental distributions in natural microbial habitats. He also aims to use microbial community genomic data to define higher order biological interactions, including metabolic interdependencies, host-parasite and symbiotic interactions, and resiliency in microbial community structure and function.
	Gerald R. Fink Herman and Margaret Sokol Professor Whitehead Institute/Massachusetts Institute of Technology Cambridge, Massachusetts Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Fink investigates the molecular biology of fungi. His current work focuses on role of sequence repeats in the organization of the fungal genome and role of fungal cell surface proteins in immune recognition.
	Peter H. Gilligan Director, Clinical Microbiology-Immunology Laboratories Director, Phlembotomy Services University of North Carolina Hospitals Professor, Departments of Microbiology-Immunology and Pathology-Laboratory Medicine University of North Carolina School of Medicine Chapel Hill, North Carolina Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Gilligan studies the microbiology of chronic lung infection in cystic fibrosis, molecular epidemiology of infectious diseases, and laboratory utilization.
	Susan Gottesman NIH Distinguished Investigator Laboratory of Molecular Biology National Cancer Institute Bethesda, Maryland Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Gottesman studies post-transcriptional regulatory mechanisms in E. coli. Her lab currently is investigating the roles of small non-coding RNAs in regulatory networks, and the mechanism of regulated proteolysis of the stationary phase sigma factor RpoS.
	Diane Griffin Professor and Chair, Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health Professor of Medicine and Neurology Johns Hopkins University School of Medicine Baltimore, Maryland Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Griffin studies the pathogenesis of viral diseases, with a particular focus on measles and alphavirus encephalitis and issues related to virulence and the role of immune responses in protection from infection and in clearance of infection.
	Carol Gross Professor, Department of Cell and Tissue Biology & Department of Microbiology and Immunology University of California, San Francisco San Francisco, California Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Gross works on the regulation of the E. coli stress response, protein interactions in the bacterial transcription apparatus, and genomic analysis of gene expression using E. coli microarrays.
	Louis Miller Chief, Malaria Vaccine Development Branch National Institutes of Health Bethesda, Maryland Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Since 1971, Dr. Miller has worked at the NIH on malaria research and is presently Chief, Malaria Vaccine Development Branch. His interests are in vaccine development, cell biology and parasitology in general. He has a strong interest in building young investigators in his field and in supporting scientists in the developing world, especially in Africa.
	Edward G. Ruby Professor and Vice-Chair, Department of Medical Microbiology and Immunology University of Wisconsin, Madison Madison, Wisconsin Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Ruby's current research activity is in bacterial quorum signaling, bacterial bioluminescence, and symbiosis-induced gene expression and genomics in the Vibrio fischeri-sepiolid squid light organ association.
	Peter K. Vogt Professor The Scripps Research Institute La Jolla, California Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Vogt has contributed to our basic understanding of retroviruses, including envelope-based classification, requirement for specific DNA synthesis in the virus replication cycle, structure of the retroviral genome, and discovery of the first oncogene, src, and its cellular counterpart. His recent work has concentrated on signaling directed by three oncoproteins he identified in retroviruses: Jun, Myc and P3k. The latter is the homolog of the catalytic subunit p110 of PI 3-kinase, which has become one of the most promising drug targets in human cancer.
	Christopher Walsh Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology Harvard University Medical School Boston, Massachusetts Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Dr. Walsh's research has focused on enzymes and enzyme inhibitors, with recent specialization on antibiotics and biosynthesis of other biologically and medicinally active natural products.